🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Status
Recruiting
Location
Mayo Clinic Cancer Center
Start Date
2026-06-12
Trial ID
NCT07104032
Treatments Being Tested
This is an open-label, multi-center, dose-escalation and dose-expansion pha...
Status
Completed
Location
GenHarp Clinical Solutions
Start Date
2020-08-07
Trial ID
NCT04434482
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
The purpose of this surveillance is to collect more safety and efficacy dat...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00704808
Treatments Being Tested
The goal of this clinical research study is to learn if the combination of ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT00504660
Treatments Being Tested
The purpose of this study is to determine treatment related toxicity, tumor...
Status
Terminated
Location
Methodist University Hospital
Start Date
2006-08
Trial ID
NCT00376103
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Unknown
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1998-09
Trial ID
NCT00003718
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
Primary Objectives: 1. To investigate the response rate (complete response...
Status
Terminated
Location
Unidad Nacional de Oncologia Pediatrica
Start Date
2012-03
Trial ID
NCT01857752
Treatments Being Tested